Big Data: the challenge for small research groups in the era of cancer genomics

Por Noor, Aisyah Mohd, Holmberg, Lars, Gillett, Cheryl, Grigoriadis, Anita
Publicado no Br J Cancer (2015)

Comparative Immunohistochemical Analysis of Ochratoxin A Tumourigenesis in Rats and Urinary Tract Carcinoma in Humans; Mechanistic Significance of p-S6 Ribosomal Protein Expression

Por Gazinska, Patrycja, Herman, Diana, Gillett, Cheryl, Pinder, Sarah, Mantle, Peter
Publicado em 2012

Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study

Por Mantle, Peter G., Dobrota, Miloslav, Gillett, Cheryl E., Odell, Edward W., Pinder, Sarah E.
Publicado em 2010

Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value

Por Joshi, Shalaka, Watkins, Johnathan, Gazinska, Patrycja, Brown, John P., Gillett, Cheryl E., Grigoriadis, Anita, Pinder, Sarah E.
Publicado no BMC Cancer (2015)

HOX transcription factors are potential targets and markers in malignant mesothelioma

Por Morgan, Richard, Simpson, Guy, Gray, Sophie, Gillett, Cheryl, Tabi, Zsuzsanna, Spicer, James, Harrington, Kevin J., Pandha, Hardev S.
Publicado no BMC Cancer (2016)

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

Por Fulford, Laura G, Reis-Filho, Jorge S, Ryder, Ken, Jones, Chris, Gillett, Cheryl E, Hanby, Andrew, Easton, Douglas, Lakhani, Sunil R
Publicado em 2007

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time

Por Melvin, Jennifer C, Purushotham, Arnie D, Garmo, Hans, Pinder, Sarah E, Fentiman, Ian S, Gillett, Cheryl, Mera, Anca, Lüctehnborg, Margreet, Holmberg, Lars, Van Hemelrijck, Mieke
Publicado no Br J Cancer (2016)

Family history of breast cancer and its association with disease severity and mortality

Por Melvin, Jennifer C., Wulaningsih, Wahyu, Hana, Zac, Purushotham, Arnie D., Pinder, Sarah E., Fentiman, Ian, Gillett, Cheryl, Mera, Anca, Holmberg, Lars, Van Hemelrijck, Mieke
Publicado no Cancer Med (2016)

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time

Por Melvin, Jennifer C, Purushotham, Arnie D, Garmo, Hans, Pinder, Sarah E, Fentiman, Ian S, Gillett, Cheryl, Mera, Anca, Lüchtenborg, Margreet, Holmberg, Lars, Van Hemelrijck, Mieke
Publicado no Br J Cancer (2016)

Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients’ survival

Por Gracio, Filipe, Burford, Brian, Gazinska, Patrycja, Mera, Anca, Mohd Noor, Aisyah, Marra, Pierfrancesco, Gillett, Cheryl, Grigoriadis, Anita, Pinder, Sarah, Tutt, Andrew, de Rinaldis, Emanuele
Publicado no Sci Rep (2017)

An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk

Por Yau, Christina, Sninsky, John, Kwok, Shirley, Wang, Alice, Degnim, Amy, Ingle, James N, Gillett, Cheryl, Tutt, Andrew, Waldman, Fred, Moore, Dan, Esserman, Laura, Benz, Christopher C
Publicado em 2013

Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control

Por de Rinaldis, Emanuele, Gazinska, Patrycja, Mera, Anca, Modrusan, Zora, Fedorowicz, Grazyna M, Burford, Brian, Gillett, Cheryl, Marra, Pierfrancesco, Grigoriadis, Anita, Dornan, David, Holmberg, Lars, Pinder, Sarah, Tutt, Andrew
Publicado em 2013

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients

Por Kelleher, Muireann T., Fruhwirth, Gilbert, Patel, Gargi, Ofo, Enyinnaya, Festy, Frederic, Barber, Paul R., Ameer-Beg, Simon M., Vojnovic, Borivoj, Gillett, Cheryl, Coolen, Anthony, Kéri, György, Ellis, Paul A., Ng, Tony
Publicado em 2009

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

Por Shah, Vandna, Nowinski, Salpie, Levi, Dina, Shinomiya, Irek, Kebaier Ep Chaabouni, Narda, Gillett, Cheryl, Grigoriadis, Anita, Graham, Trevor A., Roylance, Rebecca, Simpson, Michael A., Pinder, Sarah E., Sawyer, Elinor J.
Publicado no Breast Cancer Res (2017)

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

Por Turner, Nicholas, Pearson, Alex, Sharpe, Rachel, Lambros, Maryou, Geyer, Felipe, Lopez-Garcia, Maria A, Natrajan, Rachael, Marchio, Caterina, Iorns, Elizabeth, Mackay, Alan, Gillett, Cheryl, Grigoriadis, Anita, Tutt, Andrew, Reis-Filho, Jorge S, Ashworth, Alan
Publicado em 2010

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human brea...

Por Fredersdorf, Steffen, Burns, Jorges, Milne, Alistair M., Packham, Graham, Fallis, Lynn, Gillett, Cheryl E., Royds, Janice A., Peston, David, Hall, Peter A., Hanby, Andrew M., Barnes, Diana M., Shousha, Sami, O’Hare, Mike J., Lu, Xin
Publicado em 1997

HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status

Por Weitsman, Gregory, Barber, Paul R., Nguyen, Lan K., Lawler, Katherine, Patel, Gargi, Woodman, Natalie, Kelleher, Muireann T., Pinder, Sarah E., Rowley, Mark, Ellis, Paul A., Purushotham, Anand D., Coolen, Anthonius C., Kholodenko, Boris N., Vojnovic, Borivoj, Gillett, Cheryl, Ng, Tony
Publicado no Oncotarget (2016)

A Single-Tube Quantitative Assay for mRNA Levels of Hormonal and Growth Factor Receptors in Breast Cancer Specimens

Por Iverson, Ayuko A., Gillett, Cheryl, Cane, Paul, Santini, Christopher D., Vess, Thomas M., Kam-Morgan, Lauren, Wang, Alice, Eisenberg, Marcia, Rowland, Charles M., Hessling, Janice J., Broder, Samuel E., Sninsky, John J., Tutt, Andrew, Anderson, Steven, Chang, Sheng-Yung P.
Publicado em 2009

Biologic markers determine both the risk and the timing of recurrence in breast cancer

Por Esserman, Laura J., Moore, Dan H., Tsing, Pamela J., Chu, Philip W., Yau, Christina, Ozanne, Elissa, Chung, Robert E., Tandon, Vickram J., Park, John W., Baehner, Frederick L., Kreps, Stig, Tutt, Andrew N. J., Gillett, Cheryl E., Benz, Christopher C.
Publicado no Breast Cancer Res Treat (2011)

Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature

Por Tutt, Andrew, Wang, Alice, Rowland, Charles, Gillett, Cheryl, Lau, Kit, Chew, Karen, Dai, Hongyue, Kwok, Shirley, Ryder, Kenneth, Shu, Henry, Springall, Robert, Cane, Paul, McCallie, Blair, Kam-Morgan, Lauren, Anderson, Steve, Buerger, Horst, Gray, Joe, Bennington, James, Esserman, Laura, Hastie, Trevor, Broder, Samuel, Sninsky, John, Brandt, Burkhard, Waldman, Fred
Publicado em 2008